Strongest human evidence The METAOD006 (OPTIONS) Phase 2b trial randomized 502 adults with obesity (BMI 30-45 kg/m^2) to oral AOD-9604 (0.25, 0.5, or 1 mg/day) or placebo for 24 weeks alongside a supervised diet and exercise program
Kyvelidou C et al
Wang W, Wu Z, Lin G, Hu S, Wang B, Dai Z, et al
doi: 10.1038/s41392-023-01481-w 104 WishartDSFeunangYDMarcuAGuoACLiangKVzquez-FresnoRet al
GHKCu 100mg | 99% Purity Research Peptide 79,00 GHK-Cu 100 mg Grail Formula Quality
Clinical and research evidence shows BPC-157 can: Heal gastric and duodenal ulcers Reduce intestinal inflammation in conditions like Crohns and IBD Repair leaky gut (intestinal permeability) Counter the gut damage caused by NSAIDs, alcohol, and stress Normalize gut motility in both directions addressing both constipation and diarrhea For patients in Dubai who have cycled through conventional gut treatments without lasting results, BPC-157 represents a genuinely different approach that targets the root architecture of gut lining integrity